Severity
Moderate
FDA Devices recall · Reported July 28, 2021
Product distributed for use as an In-vitro Diagnostics without FDA clearance
Cell Marque Corporation recalled Cell Marque Antibodies, MSH6 (44), Mouse Monoclonal Antibody, REF: 287M-10, IVD, CE, GTIN… - a moderate-severity action.
Cell Marque Antibodies, MSH6 (44), Mouse Monoclonal Antibody, REF: 287M-10, IVD, CE, GTIN… was recalled by Cell Marque Corporation in July 28, 2021. Reason: Product distributed for use as an In-vitro Diagnostics without FDA clearance. Check the official notice for the remedy. Verify recall #Z-2106-2021 with the FDA Devices before acting.
The recall
Cell Marque Corporation issued this moderate-severity FDA Devices recall-Product distributed for use as an In-vitro Diagnostics without FDA clearance.
Sourced from official FDA Devices enforcement records. Verify recall #Z-2106-2021 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Devices action (record #Z-2106-2021) was formally reported on July 28, 2021, with the manufacturer initiating the action on May 27, 2021. It is classified under Moderate severity (Class II), with a current status of Terminated. Cell Marque Corporation is listed as the recalling firm, operating out of Rocklin, CA. Federal records list the affected scope as 2 units.
The documented reason for this recall is: Product distributed for use as an In-vitro Diagnostics without FDA clearance Distribution data in the federal record shows the product reached: US: AL, AR, AZ, CA, FL, HI, ID, IL, KY, MN, MT, NC, NH, NY, PA, SC, VA, WI OUS: N/A. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 3 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 40,322 medical devices recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
2 units
Related Recalls
6
3 from same agency
Cell Marque Antibodies, MSH6 (44), Mouse Monoclonal Antibody, REF: 287M-10, IVD, CE, GTIN: 00841683104513
Product distributed for use as an In-vitro Diagnostics without FDA clearance
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | Z-2106-2021 |
| Date reported | July 28, 2021 |
| Date initiated | May 27, 2021 |
| Recalling firm | Cell Marque Corporation |
| Firm location | Rocklin, CA |
| Affected scope | 2 units |
| Distribution | US: AL, AR, AZ, CA, FL, HI, ID, IL, KY, MN, MT, NC, NH, NY, PA, SC, VA, WI OUS: N/A |
Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
· 2026-07-02
· 2026-06-25
· 2026-06-18
GE Medical Systems Information Technologies Inc · 2026-06-03
Medline Industries, LP · 2026-06-03
Compare this recall with Rowenta Recalls Cordless Vacuum Cleaners Due to Risk of Ser… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Devices, reported July 28, 2021. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.